Theravance Biopharma, Inc. logo TBPH - Theravance Biopharma, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 6
HOLD 7
SELL 3
STRONG
SELL 0
| PRICE TARGET: $27.00 DETAILS
HIGH: $40.00
LOW: $14.00
MEDIAN: $27.00
CONSENSUS: $27.00
UPSIDE: 64.94%

Profitability Ratios

Ratio Value
GP Margin 94.9%
EBIT Margin -12.3%
EBITDA Margin -7.2%
Operating Margin -12.3%
Pretax Margin 120.3%
Cont. Ops Margin 98.5%
Net Margin 98.5%
Bottom Line Margin 98.5%

Liquidity Ratios

Ratio Value
Current Ratio 10.93
Quick Ratio 10.93
Solvency Ratio 0.590
Cash Ratio 4.38

Valuation Ratios

Ratio Value
Price/Earnings
8.89
Hist. avg: 4.9
Peers avg: 22.8
PEG Ratio -0.03
Forward PEG -0.03
Price/Book 3.17
Price/Sales 8.76
Price/FCF 3.95
Price/Op Cash Flow 3.95

Debt Ratios

Ratio Value
Debt/Assets 0.1555
Debt/Equity 0.2544
Debt/Capital 0.2028
Long-Term Debt/Capital 0.0995
Financial Leverage 1.64

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.42
Operating Cash Flow Ratio 6.228
Operating Cash Flow/Sales 222.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -2.32
Interest Coverage -5.3824
Short-Term Operating Cash Flow Coverage 21.79
Operating Cash Flow Coverage 3.16
Capital Expenditure Coverage 5679.55
Dividend + Capital Expenditure Coverage 5679.55

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 2.14
EPS 2.105
Debt/Share 1.5494
Cash/Share 6.27
Book Value/Share 5.90
Tangible BV/Share 5.90
Equity/Share 5.90
Operating Cash Flow/Share 4.741
Capital Expenditure/Share 0.001
FCF/Share 4.740

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.819
Earnings Before Tax/EBIT -9.757
Price/Fair Value 3.17
Debt/Market Cap 0.0465
Effective Tax Rate 18.1%
Enterprise Value Multiple -109.83